Arthur C. Butcher - 20 Nov 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP& Grp Pres, MedSurg & APAC
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
20 Nov 2023
Net transactions value
-$380,902
Form type
4
Filing time
21 Nov 2023, 16:15:03 UTC
Previous filing
22 Aug 2023
Next filing
02 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $66,606 +3,859 +34% $17.26 15,255 20 Nov 2023 Direct F1
transaction BSX Common Stock Sale $447,509 -8,278 -54% $54.06 6,977 20 Nov 2023 Direct F1
holding BSX Common Stock 2,545 20 Nov 2023 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -3,859 -32% $0.000000 8,072 20 Nov 2023 Common Stock 3,859 $17.26 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2023, intended to comply with the prior version of Rule 10b5-1(c).
F2 Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.